Brad A. Racette

10.6k total citations · 1 hit paper
139 papers, 5.1k citations indexed

About

Brad A. Racette is a scholar working on Neurology, Health, Toxicology and Mutagenesis and Cellular and Molecular Neuroscience. According to data from OpenAlex, Brad A. Racette has authored 139 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Neurology, 34 papers in Health, Toxicology and Mutagenesis and 30 papers in Cellular and Molecular Neuroscience. Recurrent topics in Brad A. Racette's work include Parkinson's Disease Mechanisms and Treatments (74 papers), Neurological disorders and treatments (36 papers) and Heavy Metal Exposure and Toxicity (26 papers). Brad A. Racette is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (74 papers), Neurological disorders and treatments (36 papers) and Heavy Metal Exposure and Toxicity (26 papers). Brad A. Racette collaborates with scholars based in United States, South Africa and United Kingdom. Brad A. Racette's co-authors include Joel S. Perlmutter, Allison W. Willis, Susan R. Criswell, Bradley Evanoff, Susan Searles Nielsen, Mario Schootman, Harvey Checkoway, Min Lian, Sandra E. Klein and Marcie Harris‐Hayes and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Bone and Joint Surgery.

In The Last Decade

Brad A. Racette

134 papers receiving 5.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of Parkinson disease in North America

2022 164 citations Allison W. Willis, Brad A. Racette et al. npj Parkinson s Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brad A. Racette United States	40	2.9k	1.1k	996	630	564	139	5.1k
Egberto Reis Barbosa Brazil	34	3.0k 1.0×	948 0.9×	436 0.4×	589 0.9×	777 1.4×	235	5.2k
Roger Pamphlett Australia	34	1.3k 0.4×	414 0.4×	635 0.6×	409 0.6×	388 0.7×	159	3.4k
Sun Ju Chung South Korea	34	2.9k 1.0×	872 0.8×	141 0.1×	516 0.8×	169 0.3×	211	4.3k
Hari Shanker Sharma Sweden	46	1.1k 0.4×	1.4k 1.3×	414 0.4×	1.4k 2.2×	212 0.4×	295	7.3k
Robert D. Fealey United States	45	2.7k 0.9×	1.1k 1.0×	261 0.3×	1.8k 2.9×	170 0.3×	78	6.1k
B. Bergamasco Italy	41	2.4k 0.8×	992 0.9×	243 0.2×	701 1.1×	109 0.2×	167	5.1k
Georg Becker Germany	44	4.5k 1.6×	1.9k 1.8×	151 0.2×	366 0.6×	362 0.6×	118	6.2k
John L. Beard United States	52	1.1k 0.4×	386 0.4×	543 0.5×	829 1.3×	2.8k 5.0×	110	8.6k
Michel Panisset Canada	33	2.4k 0.8×	625 0.6×	344 0.3×	463 0.7×	198 0.4×	94	4.1k
James W. Albers United States	49	3.7k 1.3×	1.9k 1.8×	420 0.4×	1.9k 3.1×	93 0.2×	154	8.3k

Countries citing papers authored by Brad A. Racette

Since Specialization

Citations

This map shows the geographic impact of Brad A. Racette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad A. Racette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad A. Racette more than expected).

Fields of papers citing papers by Brad A. Racette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad A. Racette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad A. Racette. The network helps show where Brad A. Racette may publish in the future.

Co-authorship network of co-authors of Brad A. Racette

This figure shows the co-authorship network connecting the top 25 collaborators of Brad A. Racette. A scholar is included among the top collaborators of Brad A. Racette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad A. Racette. Brad A. Racette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laurido-Soto, Osvaldo, et al.. (2025). Regional variability of the impact of cardiometabolic diseases on incident dementia in United States Medicare beneficiaries. Alzheimer s & Dementia. 21(5). e70199–e70199. 1 indexed citations

Racette, Brad A., et al.. (2025). Frailty in prodromal Parkinson's disease in Medicare beneficiaries. Parkinsonism & Related Disorders. 138. 107965–107965. 1 indexed citations

Delaney, Scott, et al.. (2024). The effect of air pollution on hospitalizations with Parkinson’s disease among medicare beneficiaries nationwide. npj Parkinson s Disease. 10(1). 196–196. 1 indexed citations

Nielsen, Susan Searles, et al.. (2023). Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries. Neurology. 101(21). e2058–e2067. 23 indexed citations

Kreple, Collin J., Susan Searles Nielsen, Kathleen M. Schoch, et al.. (2023). Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse Model. Annals of Neurology. 93(5). 881–892. 4 indexed citations

Song, Yizhe, Brad A. Racette, Alejandra Camacho‐Soto, & Susan Searles Nielsen. (2023). Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiaries. PLoS ONE. 18(5). e0285011–e0285011. 7 indexed citations

Racette, Brad A., Gill Nelson, Wendy W. Dlamini, et al.. (2022). Environmental manganese exposure and cognitive control in a South African population. NeuroToxicology. 89. 31–40. 13 indexed citations

Martin, W. R. Wayne, Meghan C. Campbell, Brad A. Racette, et al.. (2022). Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not Always. Annals of Neurology. 93(1). 184–195. 24 indexed citations

Racette, Brad A., Gill Nelson, Wendy W. Dlamini, et al.. (2021). Depression and anxiety in a manganese-exposed community. NeuroToxicology. 85. 222–233. 25 indexed citations

10.

Criswell, Susan R., Susan Searles Nielsen, Mark N. Warden, et al.. (2020). [11C]dihydrotetrabenazine Positron Emission Tomography in Manganese-Exposed Workers. Journal of Occupational and Environmental Medicine. 62(10). 788–794. 4 indexed citations

11.

Nelson, Gill, et al.. (2020). Validation of Parkinson’s Disease-Related Questionnaires in South Africa. Parkinson s Disease. 2020. 1–9. 5 indexed citations

12.

Racette, Brad A., et al.. (2020). Validation of a Parkinson Disease Predictive Model in a Population-Based Study. Parkinson s Disease. 2020. 1–7. 7 indexed citations

13.

Criswell, Susan R., Susan Searles Nielsen, Mark N. Warden, et al.. (2019). MRI Signal Intensity and Parkinsonism in Manganese-Exposed Workers. Journal of Occupational and Environmental Medicine. 61(8). 641–645. 28 indexed citations

14.

Camacho‐Soto, Alejandra, et al.. (2018). Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries. Parkinsonism & Related Disorders. 50. 23–28. 66 indexed citations

15.

Lin, Xiangmin, Travis J. Cook, Cyrus P. Zabetian, et al.. (2012). DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Scientific Reports. 2(1). 954–954. 85 indexed citations

16.

Criswell, Susan R., Joel S. Perlmutter, Hubert Flores, et al.. (2012). Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occupational and Environmental Medicine. 69(6). 437–443. 88 indexed citations

17.

Criswell, Susan R., Joel S. Perlmutter, Tom O. Videen, et al.. (2011). Reduced uptake of [ ¹⁸ F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology. 76(15). 1296–1301. 61 indexed citations

18.

Patra, Biswanath, Brad A. Racette, Jing Hua Zhao, et al.. (2008). LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease. Parkinsonism & Related Disorders. 15(3). 175–180. 12 indexed citations

19.

Willis, Allison W., et al.. (2007). High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy. Developmental Medicine & Child Neurology. 49(11). 818–822. 36 indexed citations

20.

Racette, Brad A., Jo Ann V. Antenor, Lori McGee‐Minnich, et al.. (2005). [¹⁸F]FDOPA PET and clinical features in parkinsonism due to manganism. Movement Disorders. 20(4). 492–496. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact